These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1832441)

  • 1. The use of meta-analysis in technology assessment: a meta-analysis of the enzyme immunosorbent assay human immunodeficiency virus antibody test.
    Phillips KA
    J Clin Epidemiol; 1991; 44(9):925-31. PubMed ID: 1832441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.
    Van Kerckhoven I; Vercauteren G; Piot P; van der Groen G
    Bull World Health Organ; 1991; 69(6):753-60. PubMed ID: 1786625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative meta-analysis on the variability in test performance among FDA-licensed enzyme immunosorbent assays for HIV antibody testing.
    Kowalski J; Tu XM; Jia G; Pagano M
    J Clin Epidemiol; 2001 May; 54(5):448-61. PubMed ID: 11337207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a rapid human immunodeficiency virus test at two community clinics in Kwazulu-Natal.
    Phili R; Vardas E
    S Afr Med J; 2002 Oct; 92(10):818-21. PubMed ID: 12432808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in HIV testing. Application and limitations of current tests.
    Cordes RJ; Ryan ME
    Postgrad Med; 1995 Nov; 98(5):177-80, 185-6, 189. PubMed ID: 7479453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of HIV-antibody assays determined by seroconversion panels.
    Constantine NT; van der Groen G; Belsey EM; Tamashiro H
    AIDS; 1994 Dec; 8(12):1715-20. PubMed ID: 7888121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
    Doyle NM; Levison JE; Gardner MO
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive human immunodeficiency virus type I ELISA results in low-risk subjects.
    Challakere K; Rapaport MH
    West J Med; 1993 Aug; 159(2):214-5. PubMed ID: 8212699
    [No Abstract]   [Full Text] [Related]  

  • 9. Reducing the cost of HIV antibody testing.
    Tamashiro H; Maskill W; Emmanuel J; Fauquex A; Sato P; Heymann D
    Lancet; 1993 Jul; 342(8863):87-90. PubMed ID: 8100916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Variables associated in multivariate analyses.
    Gerber AR; Valdiserri RO; Johnson CA; Schwartz RE; Hancock JS; Hearn TL
    Arch Pathol Lab Med; 1991 Nov; 115(11):1091-6. PubMed ID: 1747026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate use of rapid HIV antibody tests.
    Miller N; van Rooyen J; Buck R
    S Afr Med J; 1994 Oct; 84(10):696-7. PubMed ID: 7839262
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV testing in developing countries.
    Colebunders R; Beelaert G; Wellens R
    Lancet; 1997 Apr; 349(9060):1258. PubMed ID: 9130980
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva.
    Chohan BH; Lavreys L; Mandaliya KN; Kreiss JK; Bwayo JJ; Ndinya-Achola JO; Martin HL
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):346-8. PubMed ID: 11238219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
    Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV testing in low prevalence populations.
    Khan AA
    J Pak Med Assoc; 2005 Sep; 55(9):406. PubMed ID: 16302480
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV testing strategies: test performance is important, but not sufficient.
    Cota GF; de Abreu Ferrari TC; de Sousa MR
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):207-14. PubMed ID: 21342068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?
    Costagliola D; Damond F; Palmer P; Rouzioux C; Brun-Vezinet F
    AIDS; 2008 Oct; 22(15):2042-4. PubMed ID: 18784468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of commercial kits for the detection of antibody to human immunodeficiency virus type 1 (HIV-1) in Nigeria.
    Chikwem JO; Mohammed I; Ola TO
    East Afr Med J; 1990 Mar; 67(3):209-13. PubMed ID: 2191859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition ELISA using a human monoclonal antibody for detection of antibodies against human immunodeficiency virus type 1.
    Bugge TH; Hansen LL; Lindhardt BO; Kvinesdal B; Kusk P; Holmbäck K; Hulgaard E; Ulrich K
    J Virol Methods; 1991 Apr; 32(1):1-10. PubMed ID: 1712361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the concomitant use of two different EIA tests for HIV screening in blood banks.
    Otani MM; Salles NA; Barreto AM; Barreto CC; Chamone DF; Sabino EC
    Rev Panam Salud Publica; 2003; 13(2-3):172-5. PubMed ID: 12744793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.